Exabis Library
Welcome to the e-CCO Library!
P310 The efficacy of linked colour imaging, a novel endoscopic enhancement system, for diagnosing mucosal redness in ulcerative colitis patients in clinical remission
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P310: Atopic dermatitis is associated with the clinical course of Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P310: Automated digital calculation of endoscopic inflammation in ulcerative colitis: Results of the red density study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P310: Development of a new clinico-biological score associated with disease activity in patients with inflammatory bowel disease treated with thiopurine
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P310: Diagnostic delay: assessment, improvement and outcome consequences in inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P310: Is ileoanal pouch excision a destination therapy for Inflammatory Bowel Disease? Data from a quaternary pouch referral center
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P310: Patient-reported quality of life during golimumab induction for moderate-to-severe ulcerative colitis in the United Kingdom: results from the GO-COLITIS study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P310: Smoking is not an independent risk factor for surgery in patients with Crohn's Disease on biologic therapy
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P311 Detection and characterisation of extra-intestinal manifestations of IBD in clinical office notes using natural language processing
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P311: Crohn’s disease: What can we expect from the course of the disease?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P311: Depression and anxiety are associated with poor clinical outcomes in Inflammatory Bowel Disease : A Nationwide Population-Based Study in South Korea
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P311: Intensive dried blood spot sampling shows a higher drug exposure throughout the first 24 weeks of therapy in ustekinumab-treated Crohn’s disease patients achieving endoscopic remission
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P311: Microscopic inflammation and myenteric plexitis at the margin of resection do not predict endoscopic recurrence in patients with Crohn's disease after ileocolic resection
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P311: No difference in immunogenicity of the original and biosimilar infliximab in patients with inflammatory bowel disease: short-term results
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P311: Pharmacokinetics and exposure–response relationships of intravenously administered ustekinumab during induction treatment in patients with ulcerative colitis: Results from the UNIFI induction study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P311: Reliability of computed tomography enterography for evaluation of stricturing Crohn's disease: Development of a Crohn's disease stricture index
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P312 Introduction of bowel ultrasonography for follow-up of paediatric inflammatory bowel disease: A single-centre experience
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P312: Combination corticosteroids with 5-aminosalicylic acid versus corticosteroids alone in the treatment of hospitalized patients with acute severe ulcerative colitis: A multi-center randomized controlled trial
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P312: Efficacy in biologic failure and non-biologic-failure populations in a Phase 3 study of ustekinumab in moderate–severe ulcerative colitis: UNIFI
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P312: Erythrocyte methotrexate polyglutamate concentrations in patients with Crohn's Disease: towards a new therapeutic drug monitoring tool
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM